China-Based Pharmaceutical Manufacturing Partner

A leading China-based pharmaceutical manufacturer with more than three decades of industry experience, supporting global healthcare companies through integrated development and commercial manufacturing services. Founded in 1990, the organization combines large-scale production capabilities with strong scientific expertise, serving both domestic and international markets.

The company offers end-to-end manufacturing solutions across finished dosage forms and active pharmaceutical ingredients (APIs), with capabilities spanning oral solid doses, specialty pharmaceutical products, and complex small-molecule manufacturing. Its vertically integrated structure supports reliable supply chains, quality oversight, and efficient technology transfer for both established products and lifecycle management initiatives.

Operating from modern manufacturing facilities in China, the organization has extensive experience supporting international regulatory requirements and global commercialization programs. Continuous investment in research, development, and process improvement enables the delivery of scalable manufacturing solutions while maintaining a strong focus on quality, compliance, and operational excellence.

As part of the TrueNorth network, this partner represents a strong option for companies seeking cost-competitive pharmaceutical manufacturing, technology transfer support, and access to a proven Asian supply platform with experience serving regulated markets worldwide. Based on internal Karo sourcing activities, the site has been selected for technology transfer projects and manufactures products under EU GMP requirements.